Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1984;69:618-631

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bernabei, R.
Right arrow Articles by Vassalle, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bernabei, R.
Right arrow Articles by Vassalle, M.

Circulation, Vol 69, 618-631, Copyright © 1984 by American Heart Association


ARTICLES

The inotropic effects of strophanthidin in Purkinje fibers and the sodium pump

R Bernabei and M Vassalle

The role of the inhibition of the Na pump in strophanthidin inotropy was studied in canine Purkinje fibers by correlating changes in contractile force with changes in maximum diastolic potential caused by conditions that enhance the electrogenic extrusion of Na. It was found that a brief exposure to a zero-K or to a zero-K, zero-Ca solution (but not to a zero-Ca solution) is followed by an increase in maximum diastolic potential. This hyperpolarization is reduced if NaCl is substituted by LiCl and in the presence of tetrodotoxin. In quiescent fibers exposed to tetrodotoxin, the hyperpolarization is abolished. A low concentration of strophanthidin (5 X 10(-8)M) increases contractile force but does not modify the hyperpolarization. Larger strophanthidin concentrations (5 X 10(-7)M to 10(-6)M) increase and then decrease contractile force and reduce or abolish the hyperpolarization. Metabolic inhibitors also reduce the hyperpolarization. We conclude that the positive inotropic effect of a low (therapeutic) concentration of strophanthidin is due to a mechanism other than Na pump inhibition.